pseudococaine: dextro-isomer & C epimer of cocaine; see also record for COCAINE which is the (1R-(exo,exo))-isomer; RN given refers to (1R-(2endo,3exo))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 644005 |
SCHEMBL ID | 26608 |
MeSH ID | M0065836 |
Synonym |
---|
unii-277eep3rja |
8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(2-endo,3-exo))- |
277eep3rja , |
pseudococaine, (+) |
pseudococaine |
depsococaine |
isococaine |
8-azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, [1r-(2-endo,3-exo)]- |
2alpha-carbomethoxy-3beta-benzoyloxytropane |
isococain |
dextrocaine |
8-azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r,2s,3s,5s)- |
(+)-pseudococaine |
d-phi-cocaine |
478-73-9 |
d-pseudococaine |
1alphah,5alphah-tropane-2alpha-carboxylic acid, 3beta-hydroxy-, methyl ester, benzoate (ester) (8ci) |
delcaine |
(r)-pseudococaine |
pseudococaine (6ci,7ci) |
(1r,2s,3s,5s)-3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid methyl ester |
8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r,2s,3s,5s)- |
pseudococaine [mi] |
SCHEMBL26608 |
DTXSID20858949 |
methyl (1r,2s,3s,5s)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate |
Q27254174 |
AKOS040734874 |
Excerpt | Relevance | Reference |
---|---|---|
" A linear dose-response relationship was observed for the suppressive effect of cocaine on the AD." | ( Cocaine and pseudococaine: comparative effects on electrical after-discharge in the limbic system of cats. Matsuzaki, M; Misra, AL, ) | 0.51 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 3 (42.86) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.81) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |